Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today ...

Laboratory Corporation of America Holdings LH, popularly known as LabCorp, recently launched the Neurofilament Light Chain (NfL) blood test to facilitate the detection and verification of the signs of ...

Laboratory testing plays a critical role in healthcare, informing nearly 70% of clinical decisions and often serving as the first step in diagnosing and managing patient conditions. Yet research shows ...

The GFAP blood biomarker test complements Labcorp’s existing neurology tests. Credit: PaeGAG/Shutterstock.com. Global life sciences company Labcorp has announced the first commercially available glial ...

BURLINGTON, N.C., July 30, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its LabCorp 2019 Novel Coronavirus (COVID-19 ...

The test allows oncologists to offer personalised, targeted therapy plan for patients. Credit: fernando zhiminaicela from Pixabay. Global life sciences company Labcorp has introduced a new liquid ...

[Image from LabCorp] Labcorp (NYSE:LH) announced today that it launched a test that provides direct evidence of neurodegeneration and neuronal injury. Burlington, North Carolina-based Labcorp designed ...

BURLINGTON – Labcorp has opened a new testing program for cancer patients, sponsored by Eli Lilly and Company, which is also expanding its operations and footprint in North Carolina with a new ...

Laboratory Corporation of America Holdings LH, known as LabCorp, recently launched the Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE ...

Hologic trades at a forward one-year price-to-sales (P/S) of 3.86X, higher than its median. In contrast, Labcorp’s forward ...